-
The application of nanoparticle-mediated siRNA delivery systems in ovarian cance
Author: Qian, Xueqian; Yuan, Yi; Zhang, Yaning; Dou, Zemin; Gao, Chengjin; Han, Yangyang
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01020-z
-
Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate cancer in mic
Author: Li, Dan; Gu, Xinyu; Li, Jing; Huang, Yong; Zhou, Wei-Lin; Li, Jiaqian; Wang, Fengling; Yan, Feiyang; Gao, Haozhan; Ying, Xue; Li, Yikun; Qi, Shimao; Zhu, Yueting; Liu, Jiyan; Wang, Wei
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01025-8
-
Deciphering the role of SIRT6 in suppressing the AMPK-mTOR-TFEB axis: regulation of autophagy activation in HC
Author: Li, Cong Shan; Jin, Hua; Meng, Ruoyu; Baek, Seung-Woo; Kim, Seong-Hun; Chai, Ok Hee; Park, Byung Hyun; Lee, Ju-Seog; Lee, Na Ri; Kim, Soo Mi
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01023-w
-
Blood-brain barrier breakdown in traumatic brain injury: current insights and future direction
Author: Wu, Haijian; Zheng, Jingwei; Xu, Weilin; Zhou, Fengqi; Lenahan, Cameron; Giamas, Georgios; Wang, Chun; Zhang, Jianmin; Ji, Jianxiong
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01027-6
-
WTAP stabilized by USP7 contributes to enzalutamide resistance in prostate cancer via mediating AKT m6A-modificatio
Author: Shi, Ruxue; Gu, Kai; Li, Haichuan; Sun, Qingwei; Wu, Xinyu; Huang, Shuhong; Hu, Qingxia
Journal: CANCER GENE THERAPY. 2026; Vol. 33, Issue 3, pp. 277-288. DOI: 10.1038/s41417-026-01013-y
-
COL3A1 promotes gastric cancer progression by activating PI3K/AKT signalin
Author: Mao, Xiaqiong; Li, Wei; Guan, Yue; Kuai, Xiaoyi; Yuan, Jie
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01011-0
-
Gracillin overcomes osimertinib resistance in NSCLC via dual inhibition of EGFR and Mcl-
Author: Liao, Jinzhuang; Liang, Qi; Wu, Xuecheng; Li, Dongyu; Liu, Yiwei; Han, Shuangze; Wang, Ruirui; Guo, Pengfei; Yi, Ming; Li, Wei
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01016-9
-
Dioscin suppresses tumorigenesis and overcomes radioresistance by promoting ubiquitination-mediated degradation of Mcl-
Author: Liang, Qi; Wu, Xuecheng; Li, Dongyu; Liu, Yiwei; Wang, Ruirui; Li, Xiaoying; Guo, Pengfei; Li, Wei
Journal: CANCER GENE THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41417-026-01022-x
